ZLAB Competitors & Alternatives

Compare Zai Lab Ltd with similar stocks in the same industry

Biotechnology

ZLAB

Main Stock
$23.74
-3.50%
Tradestie Score
44
Market Cap
$3.83B
Revenue Growth
-6.8%
Analyst Upside
+43.7%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: small_molecule_inhibitors, antibody_therapies, in-licensing_platform
Major Customers 5
hospitals oncology clinics specialty pharmacies healthcare providers patients via reimbursement
Critical Suppliers 4
contract manufacturing organizations API suppliers clinical CROs licensing partners
Direct Ecosystem Rivals 4

Top Competitors

219 stocks in Biotechnology
Company Price Market Cap P/E Score Action
SLNO Soleno Therapeutics, Inc. Common Stock
$53.01
+0.04%
$3.20B 27.5 48 Compare
MLYS Mineralys Therapeutics, Inc. Common Stock
$14.79
-3.52%
$3.09B - 59 Compare
VKTX Viking Therapeutics, Inc
$26.89
-7.99%
$3.08B - 39 Compare
CNTA Centessa Pharmaceuticals plc American Depositary Shares
$40.50
+0.80%
$3.03B - 48 Compare
XENE Xenon Pharmaceuticals Inc
$39.66
-2.03%
$3.02B - 33 Compare
CGON CG Oncology, Inc. Common stock
$84.95
+14.17%
$3.01B - 34 Compare
APLS Apellis Pharmaceuticals, Inc. Common Stock
$41.03
-0.07%
$2.92B 38.3 50 Compare
RARE Ultragenyx Pharmaceutical Inc.
$15.97
-0.72%
$2.89B - 42 Compare
IMVT Immunovant, Inc. Common Stock
$33.22
-2.81%
$2.85B - 34 Compare
HCM HUTCHMED (China) Limited American Depositary Shares
$14.69
-1.44%
$2.74B 148.3 37 Compare

Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)

219 stocks in this industry